Articles
Swedish company Follicum has announced new information regarding their clinical trial schedule and product development. The last completed milestone we had heard from Follicum was results from their phase 2a clinical trial of FOL-005. During that trial which completed in late 2018, the peptide FOL-005 was injected into the scalps of 60 participants three times…
Read More
One of the most popular hair-growth research discoveries in recent years is finally making its way into clinical trials. If successful, a product could become available sooner than expected. In May 2018, an article published in the PLOS journal by Hawkshaw et al., showed that SFRP1 inhibition was a novel way of promoting human hair…
Read More
Update 3/20/20 New HairCell Results Posted Last week, the HairCell company shared more photo results from their pilot trial which is ongoing in South Africa. There are now 6 new before and after comparisons on the HairCell website. Below, I’ve shared one of the best results from the new data posted. Subject “Jason” appears to…
Read More
In this article, Follicle Thought talks “all things hair science” with one of the most prolific hair biology researchers in the field, Dr. Ralf Paus. A recent publication from The Guardian featuring several of the latest technologies being developed to treat hair loss included some interesting remarks from Dr. Paus. Coincidentally, I had conducted a…
Read More
SM04554, a Wnt activator from Samumed, is currently the only new drug worldwide at a phase 3 trial for androgenic alopecia. Last month, Samumed’s CEO Osman Kibar was featured in a Fierce Biotech article which covered Samumed’s various programs for oncology, arthritis, and of course – alopecia. At the end of the article there was…
Read MoreJ. Hewitt, a regenerative medicine company from Japan, has told Follicle Thought they plan to start a pivotal hair multiplication clinical trial in Japan by the end of the year. J.Hewitt & TissUse SHT Collaboration In early 2019, TissUse issued a press release announcing it had granted J. Hewitt of Japan the first license to…
Read More
It’s always pleasing to learn of new companies who are developing drugs to treat hair loss. The more companies there are in the pipeline, the greater the chances are for success. Kintor Pharmaceuticals of China is the latest company to enter the global pharma market of alopecia treatments. Kintor Pharmaceuticals Pipeline There are two listed…
Read More
Aclaris Therapeutics issued a press release on August 8, 2019 which outlined a new direction for their multiple alopecia programs. Additionally, Aclaris recently presented data from its second alopecia areata trial of the year. Looking For Partners There has been a mix of results from Aclaris’ three alopecia trials completed this year. Things started off…
Read MoreAs we get further into the year of 2019 the majority of the online crowd is intently watching for an update from the pivotal RCH-01 trial being sponsored by Shiseido in Japan. Three Years In Japan To recap, back in July 2016, Replicel and Shiseido made headlines by announcing that Shiseido’s trial of the RCH-01…
Read More
Published on: Aug 1, 2019 at 12:32
Read More